CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism

Paavo Pietarinen, Perttu Koskenvesa, Judith Klievink, Kimmo Porkka, Mikko Niemi, Satu Mustjoki

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Issue number22
Number of pages4
Publication statusPublished - 2 Dec 2016
Event58th Annual Meeting and Exposition of the American-Society-of-Hematology - San Diego, Canada
Duration: 3 Dec 20166 Dec 2016

Cite this